CPCynthia Parker
Cynthia Parker
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Cynthia Parker has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Cunningham
BioCryst Pharmaceuticals, 2190 Parkway Lake Drive, Suite B, Birmingham, AL 35244, USA
1 shared publication - J. Michael Kilpatrick
BioCryst Pharmaceuticals, 2190 Parkway Lake Drive, Suite B, Birmingham, AL 35244, USA
1 shared publication Philip Morris
BioCryst Pharmaceuticals, 2190 Parkway Lake Drive, Suite B, Birmingham, AL 35244, USA
1 shared publication- Pooran Chand
BioCryst Pharmaceuticals, 2190 Parkway Lake Drive, Suite B, Birmingham, AL 35244, USA
1 shared publication - Pravin L. Kotian
Department of Biology, BioCryst Pharmaceuticals Inc., Discovery Center of Excellence , Birmingham, AL 35244
1 shared publication - Ramanda Upshaw
Department of Biological Sciences, BioCryst Pharmaceuticals, Inc., 2190 Parkway Lake Drive, Birmingham, AL 35244, USA
1 shared publication
Latest Publications
- 22 April 2010
- Published by Elsevier in International Immunopharmacology
- Vol. 10 (7) , 784-790
Potent orally bioavailable purine nucleoside phosphorylase inhibitor BCX-4208 induces apoptosis in B- and T-lymphocytes—A novel treatment approach for autoimmune diseases, organ transplantation and hematologic malignancies
- 22 April 2010
- Published by Elsevier in International Immunopharmacology
- Vol. 10 (7) , 784-790
Potent orally bioavailable purine nucleoside phosphorylase inhibitor BCX-4208 induces apoptosis in B- and T-lymphocytes—A novel treatment approach for autoimmune diseases, organ transplantation and hematologic malignancies